Welcome Guest

Table of Contents

Volume 1 |  Issue 2

Publication Date: August 2001
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
75
Clinical Colorectal Cancer: Oral Chemotherapy Comes of Age
Edward Chu
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
76-81
37th Annual Meeting of the American Society of Clinical Oncology; San Francisco, CA; May 12-15, 2001
Kavita Maung, Amy I. D’Orazio, Romano Danesi, Sitki Copur
  • Abstract
  • No Access
  • Add to Cart
Researches in Brief
Page Number of this Article in the Print Version
82-84
Recommendation for Irinotecan, 5-Fluorouracil, and Leucovorin as First-Line Therapy for Colorectal Cancer
Maxine D. Fisher, Leonard Saltz, Richard Goldberg, Richard Schilsky
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
85-86
Irinotecan/5-FU/Leucovorin, Oxaliplatin/5-FU/Leucovorin, and Oxaliplatin/Irinotecan Are Each Effective in the Treatment of 5-FU–Resistant Advanced Colorectal Cancer
Maxine D. Fisher, Edward Chu
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Reviews
Page Number of this Article in the Print Version
87-94
Review of the Role of CPT-11 in the Treatment of Colorectal Cancer
Philippe Rougier, Emmanuel Mitry
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
95-103
Oral Fluoropyrimidine Treatment of Colorectal Cancer
Cathy Eng, Hedy L. Kindler, Richard L. Schilsky
  • Abstract
  • No Access
  • Add to Cart
Original Contribution
Page Number of this Article in the Print Version
104-109
Microsatellite Instability Is a Predictive Marker for Survival Benefit from Adjuvant Chemotherapy in a Population-Based Series of Stage III Colorectal Carcinoma
Hany Elsaleh, Barry Iacopetta
  • Abstract
  • No Access
  • Add to Cart
Translational Medicine
Page Number of this Article in the Print Version
110-116
Detection of Mutated K12-ras in Histologically Negative Lymph Nodes as an Indicator of Poor Prognosis in Stage II Colorectal Cancer
Robert T. Belly, Joseph D. Rosenblatt, Michele Steinmann, Jacqueline Toner, Jianbo Sun, Joseph Shehadi, James L. Peacock, Richard F. Raubertas, Niraj Jani, Charlotte K. Ryan
  • Abstract
  • No Access
  • Add to Cart
Case Report
Page Number of this Article in the Print Version
117-120
Positron Emission Tomography for the Evaluation of Patients with Colorectal Cancer
Miklos C. Fogarasi, Richard S. Zelkowitz, Stephen A. Messana, James A. Arrighi, John P. Seibyl, Shivaani Kummar
  • Abstract
  • No Access
  • Add to Cart
Clinical Commentary
Page Number of this Article in the Print Version
121-127
Chemotherapeutic Strategies for Treatment of Colorectal Cancer: Present and Future Developments
Harold H.J. Backus, Youcef M. Rustum, Cornelius J. van Groeningen, Godefridus J. Peters
  • Abstract
  • No Access
  • Add to Cart